GIJHSR

Galore International Journal of Health Sciences and Research


Year: 2024 | Month: January-March | Volume: 9 | Issue: 1 | Pages: 59-71

DOI: https://doi.org/10.52403/gijhsr.20240107

The Relationship Between Citicoline Administration and the National Institute of Health Stroke Scale in Hemorrhagic Stroke Patients at Dr. Regional General Hospital Chasbullah Abdulmadjid Bekasi City in 2022

Tranggono Yudo Utomo1,3, Fanessa Pingkan Widytri Nugroho2, Agus Yudawijaya1

1Department of Neuroscience, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
2Medical Student, Faculty of Medicine, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
3Regional General Hospital, Dr. Chasbullah Abdulmadjid, Bekasi, Indonesia

Corresponding Author: Tranggono Yudo Utomo

ABSTRACT

Background: Hemorrhagic stroke is a focal or generalized neurological deficit that occurs suddenly within seconds or hours caused by a ruptured blood vessel. Hemorrhagic stroke can be divided into Intracerebral Hemorrhage (ICH) and Subarachnoid Hemorrhage (SAH). The prevalence of stroke in Indonesia, according to Riskesdas, in 2018 reached 10.9%; the highest cases occurred at the age of ≥55 years and were dominated by men. Treatment of hemorrhagic stroke can use citicoline as a neuroprotectant to repair brain cell membranes. One of the tools that can be used if there is a neurological deficit is the National Institute of Health Stroke Scale (NIHSS), which is useful for assessing the state of improvement of post-stroke patients.
Purpose: To determine the relationship between the administration of citicoline and the NIHSS of hemorrhagic stroke patients.
Methods: Descriptive analytics with a cross-sectional design using medical record data from the Regional General Hospital dr. Chasbullah Abdulmadjid Bekasi City had 95 patients based on the inclusion criteria.
Results: The data from this study were processed using the Chi-Square test, which showed a significant relationship between citicoline administration and the NIHSS in hemorrhagic stroke patients with p-value = 0.017 (p <0.05).
Conclusion: The administering of citicoline therapy in hemorrhagic stroke patients improved the NIHSS score.

Keywords: Hemorrhagic stroke, Citicoline, NIHSS

[PDF Full Text]